TABLE OF CONTENTS
|  |  |  | Volume 36, Issue 33 (August 2017) |  | In this issue Review Original Articles Short Communications Corrigenda
Also new    AOP | |  |  |  | | Advertisement |  | | |  |  | Review | Top |  | New factors in mammalian DNA repair—the chromatin connection OPENG Raschellà, G Melino and M Malewicz Oncogene 2017 36: 4673-4681; advance online publication, April 10, 2017; 10.1038/onc.2017.60 Abstract | Full Text |  | Original Articles | Top |  | PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastomaV Colicchia, M Petroni, G Guarguaglini, F Sardina, M Sahún-Roncero, M Carbonari, B Ricci, C Heil, C Capalbo, F Belardinilli, A Coppa, G Peruzzi, I Screpanti, P Lavia, A Gulino and G Giannini Oncogene 2017 36: 4682-4691; advance online publication, April 10, 2017; 10.1038/onc.2017.40 Abstract | Full Text |  |  |  | Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b OPENY Chen, C Zeng, Y Zhan, H Wang, X Jiang and W Li Oncogene 2017 36: 4692-4705; advance online publication, April 10, 2017; 10.1038/onc.2017.100 Abstract | Full Text |  |  |  | NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant gliomaP-S Hu, Q-S Xia, F Wu, D-k Li, Y-j Qi, Y Hu, Z-Z Wei, S-S Li, N-Y Tian, Q-F Wei, L-J Shen, B Yin, T Jiang, J-G Yuan, B-Q Qiang, W Han and X-Z Peng Oncogene 2017 36: 4706-4718; advance online publication, April 10, 2017; 10.1038/onc.2017.34 Abstract | Full Text |  |  |  | Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA OPENW Lu, F Cheng, W Yan, X Li, X Yao, W Song, M Liu, X Shen, H Jiang, J Chen, J Li and J Huang Oncogene 2017 36: 4719-4731; advance online publication, April 10, 2017; 10.1038/onc.2017.41 Abstract | Full Text |  |  |  | Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cellsA Motzik, E Amir, T Erlich, J Wang, B-G Kim, J M Han, J H Kim, H Nechushtan, M Guo, E Razin and S Tshori Oncogene 2017 36: 4732-4738; advance online publication, April 10, 2017; 10.1038/onc.2017.81 Abstract | Full Text |  |  |  | CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer OPENE Zoni, L Chen, S Karkampouna, Z Granchi, E I Verhoef, F La Manna, J Kelber, R C M Pelger, M D Henry, E Snaar-Jagalska, G J L H van Leenders, L Beimers, P Kloen, P C Gray, G van der Pluijm and M Kruithof-de Julio Oncogene 2017 36: 4739-4749; advance online publication, April 10, 2017; 10.1038/onc.2017.87 Abstract | Full Text |  |  |  | Regulation of spindle integrity and mitotic fidelity by BCCIP OPENS C Huhn, J Liu, C Ye, H Lu, X Jiang, X Feng, S Ganesan, E White and Z Shen Oncogene 2017 36: 4750-4766; advance online publication, April 10, 2017; 10.1038/onc.2017.92 Abstract | Full Text |  |  |  | SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoproteinC Geng, S Kaochar, M Li, K Rajapakshe, W Fiskus, J Dong, C Foley, B Dong, L Zhang, O-J Kwon, S S Shah, M Bolaki, L Xin, M Ittmann, B W O'Malley, C Coarfa and N Mitsiades Oncogene 2017 36: 4767-4777; advance online publication, April 17, 2017; 10.1038/onc.2017.80 Abstract | Full Text |  |  |  | Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumoursH Yurugi, F Marini, C Weber, K David, Q Zhao, H Binder, L Désaubry and K Rajalingam Oncogene 2017 36: 4778-4789; advance online publication, April 17, 2017; 10.1038/onc.2017.93 Abstract | Full Text |  |  |  | Complex regulation of LCoR signaling in breast cancer cells OPENS Jalaguier, C Teyssier, T Nait Achour, A Lucas, S Bonnet, C Rodriguez, N Elarouci, M Lapierre and V Cavaillès Oncogene 2017 36: 4790-4801; advance online publication, April 17, 2017; 10.1038/onc.2017.97 Abstract | Full Text |  | Short Communications | Top |  | DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancerS Hernández-Pérez, E Cabrera, E Salido, M Lim, L Reid, S R Lakhani, K K Khanna, J M Saunus and R Freire Oncogene 2017 36: 4802-4809; advance online publication, March 13, 2017; 10.1038/onc.2017.21 Abstract | Full Text |  |  |  | Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasiaE T Sumner, A T Chawla, A D Cororaton, J E Koblinski, R C Kovi, I M Love, B B Szomju, S Korwar, K C Ellis and S R Grossman Oncogene 2017 36: 4810-4816; advance online publication, April 17, 2017; 10.1038/onc.2017.106 Abstract | Full Text |  | Corrigenda | Top |  | DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancerS Hernández-Pérez, E Cabrera, E Salido, M Lim, L Reid, S R Lakhani, K K Khanna, J M Saunus and R Freire Oncogene 2017 36: 4817; advance online publication, June 26, 2017; 10.1038/onc.2017.220 Full Text |  |  |  | Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatmentB Joseph, P Marchetti, P Formstecher, G Kroemer, R Lewensohn and B Zhivotovsky Oncogene 2017 36: 4818; advance online publication, April 10, 2017; 10.1038/onc.2017.78 Full Text |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment